CALR and neoplasm: For instance, in orthotopic mouse glioma models, NDV immunotherapy has been shown to increase calreticulin translocation to the cell surface and extracellular accumulation of high mobility group box 1 and a tumor-specific immune response and long-term tumor regulation [63, 64].